Nephros Stock Buy Hold or Sell Recommendation


USD 0.93  0.02  2.20%   

Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Nephros is 'Strong Sell'. Macroaxis provides Nephros buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Nephros positions. The advice algorithm takes into account all of Nephros' available fundamental, technical, and predictive indicators you will find on this site.
The advice is provided from Nephros' buy-and-hold perspective. Additionally, see Nephros Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. We conduct extensive research on individual companies such as Nephros and provide practical buy, sell, or hold advice based on selected investing horizon and risk tolerance towards Nephros.

Execute Nephros Buy or Sell Advice

The Nephros recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Nephros. Macroaxis does not own or have any residual interests in Nephros or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Nephros' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell NephrosBuy Nephros
Strong Sell



Hype Condition


Current Valuation


Odds of Distress


Economic Sensitivity


Analyst Consensus


Reporting Quality (M-Score)

For the selected time horizon Nephros has a Mean Deviation of 2.59, Standard Deviation of 3.59 and Variance of 12.9
We provide investment recommendation to complement the last-minute expert consensus on Nephros. Our dynamic recommendation engine harnesses a multidimensional algorithm to analyze the entity's potential to grow using all technical and fundamental data available at the time. To make sure Nephros is not overpriced, please verify all Nephros fundamentals, including its debt to equity, market capitalization, and the relationship between the net income and short ratio . As Nephros appears to be a penny stock we also strongly suggest to check its number of shares shorted numbers.

Nephros Trading Alerts and Improvement Suggestions

Nephros generated a negative expected return over the last 90 days
Nephros has some characteristics of a very speculative penny stock
Nephros has high historical volatility and very poor performance
Nephros has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 9.86 M. Net Loss for the year was (5.54 M) with profit before overhead, payroll, taxes, and interest of 5.74 M.
Nephros currently holds about 5.42 M in cash with (3.16 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.52.
Latest headline from Nephros Partners with Donastar and Tractor Beverage Company to Supply and Service Nationwide Fast-Casual Restaurant Operation - Yahoo Finance

Nephros current analysts advice

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Nephros analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Nephros analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Mean Price7.63
Target Median Price7.63
Target High Price10.00
Recommendation Mean2.30
Number Of Analyst Opinions2
Target Low Price5.25
Average Consensus Strong Buy
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.

Nephros Returns Distribution Density

The distribution of Nephros' historical returns is an attempt to chart the uncertainty of Nephros' future price movements. The chart of the probability distribution of Nephros stock daily returns describes the distribution of returns around its average expected value. We use Nephros price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Nephros returns is essential to provide solid investment advice for Nephros.
Mean Return-0.69Value At Risk-5.3
Potential Upside4.73Standard Deviation3.59
   Return Density   
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Nephros historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Nephros Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Nephros is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Nephros backward and forwards among themselves. Nephros' institutional investor refers to the entity that pools money to purchase Nephros' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Wexford Capital LpCommon Shares3.7 M174.7 M
Bard Associates IncCommon Shares263.8 K404 K
Vanguard Group IncCommon Shares122.7 K188 K
Hightower Advisors LlcCommon Shares55.7 K85 K
Cowen Prime Advisors LlcCommon Shares42.5 K65 K
Blair William CoCommon Shares36.2 K55 K
Elkhorn Partners Limited PartnershipCommon Shares34 K52 K
Note, although Nephros' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Nephros Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Nephros or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Nephros' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Nephros stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Alpha over DOW
Beta against DOW0.46
Overall volatility
Information ratio -0.18

Nephros Volatility Alert

Nephros exhibits very low volatility with skewness of 0.37 and kurtosis of 3.3. However, we advise investors to further study Nephros technical indicators to ensure that all market info is available and is reliable. Nephros is a potential penny stock. Although Nephros may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Nephros. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Nephros instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.

Nephros Fundamentals Vs Peers

Comparing Nephros' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Nephros' direct or indirect competition across all of the common fundamentals between Nephros and the related equities. This way, we can detect undervalued stocks with similar characteristics as Nephros or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Nephros' fundamental indicators could also be used in its relative valuation, which is a method of valuing Nephros by comparing valuation metrics with those of similar companies.
 Better Than Average     
 Worse Than Average Compare Nephros to competition
FundamentalsNephrosPeer Average
Return On Equity(36.61) %(0.31) %
Return On Asset(19.69) %(0.14) %
Profit Margin(56.22) %(1.27) %
Operating Margin(53.47) %(5.51) %
Current Valuation14.16 M16.62 B
Shares Outstanding10.23 M571.82 M
Shares Owned by Insiders10.15 %10.09 %
Shares Owned by Institutions46.91 %39.21 %
Number of Shares Shorted32.73 K4.71 M
Price to Earning(4.51) X28.72 X
Price to Book0.75 X9.51 X
Price to Sales0.99 X11.42 X
Revenue9.86 M9.43 B
Gross Profit5.74 M27.38 B
EBITDA(4.98 M)3.9 B
Net Income(5.54 M)570.98 M
Cash and Equivalents5.42 M2.7 B
Cash per Share0.52 X5.01 X
Total Debt966 K5.32 B
Debt to Equity0.07 %48.70 %
Current Ratio6.67 X2.16 X
Book Value Per Share1.27 X1.93 K
Cash Flow from Operations(3.16 M)971.22 M
Short Ratio1.30 X4.00 X
Earnings Per Share(0.53) X3.12 X
Number of Employees3418.84 K
Market Capitalization9.75 M19.03 B
Total Asset3.01 M29.47 B
Retained Earnings(137.38 M)9.33 B
Working Capital848 K1.48 B
Current Asset1.53 M9.34 B
Current Liabilities684 K7.9 B
   Acquisition by Harris Joseph Michael of 13115 shares of Nephros subject to Rule 16b-3 [view details]

Nephros Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Nephros . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Nephros Buy or Sell Advice

When is the right time to buy or sell Nephros? Buying financial instruments such as Nephros Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Nephros in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Top Penny Thematic Idea Now

Top Penny
Top Penny Theme
Solid stocks, funds or ETFs with above average market capitalization and strong fundamental indicators based on Macroaxis rating system. The Top Penny theme has 20 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Top Penny Theme or any other thematic opportunities.
View All  Next Launch
Additionally, see Nephros Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Complementary Tools for analysis

When running Nephros price analysis, check to measure Nephros' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nephros is operating at the current time. Most of Nephros' value examination focuses on studying past and present price action to predict the probability of Nephros' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Nephros' price. Additionally, you may evaluate how the addition of Nephros to your portfolios can decrease your overall portfolio volatility.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Global Correlations
Find global opportunities by holding instruments from different markets
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Is Nephros' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nephros. If investors know Nephros will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nephros listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Nephros is measured differently than its book value, which is the value of Nephros that is recorded on the company's balance sheet. Investors also form their own opinion of Nephros' value that differs from its market value or its book value, called intrinsic value, which is Nephros' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nephros' market value can be influenced by many factors that don't directly affect Nephros' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nephros' value and its price as these two are different measures arrived at by different means. Investors typically determine Nephros value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nephros' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.